178 related articles for article (PubMed ID: 26212144)
1. Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data.
Jimenez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Rodriguez C; Vega T; Quinones C; Martinez E; Vanrell JM; Gimenez J; Castrillejo D; Altzibar JM; Carril F; Ramos JM; Serrano MC; Martinez A; Torner N; Perez E; Gallardo V; Larrauri A;
Euro Surveill; 2015 Jul; 20(28):. PubMed ID: 26212144
[TBL] [Abstract][Full Text] [Related]
2. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.
Savulescu C; Jiménez-Jorge S; de Mateo S; Pozo F; Casas I; Breña PP; Galmés A; Vanrell JM; Rodriguez C; Vega T; Martinez A; Torner N; Ramos JM; Serrano MC; Castilla J; Cenoz MG; Altzibar JM; Arteagoitia JM; Quiñones C; Perucha M; Larrauri A
BMC Public Health; 2011 Nov; 11():899. PubMed ID: 22129083
[TBL] [Abstract][Full Text] [Related]
3. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.
Jimenez-Jorge S; Pozo F; de Mateo S; Delgado-Sanz C; Casas I; Garcia-Cenoz M; Castilla J; Sancho R; Etxebarriarteun-Aranzabal L; Quinones C; Martinez E; Vega T; Garcia A; Gimenez J; Vanrell JM; Castrillejo D; Larrauri A;
Euro Surveill; 2014 Mar; 19(9):. PubMed ID: 24626206
[TBL] [Abstract][Full Text] [Related]
6. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.
Larrauri A; Savulescu C; Jiménez-Jorge S; Pérez-Breña P; Pozo F; Casas I; Ledesma J; de Mateo S;
Gac Sanit; 2011; 25(1):23-8. PubMed ID: 21334788
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.
Jiménez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Pérez E; Gallardo V; Rodriguez C; Vega T; Quiñones C; Martínez E; Vanrell JM; Giménez J; Castrillejo D; Serrano Mdel C; Ramos JM; Larrauri A;
BMC Infect Dis; 2013 Sep; 13():441. PubMed ID: 24053661
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
9. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.
Jiménez-Jorge S; Pozo F; Larrauri A;
Vaccine; 2015 Jun; 33(29):3276-80. PubMed ID: 25869892
[TBL] [Abstract][Full Text] [Related]
10. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
Kissling E; Valenciano M;
Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
[TBL] [Abstract][Full Text] [Related]
11. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
[TBL] [Abstract][Full Text] [Related]
12. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
[TBL] [Abstract][Full Text] [Related]
13. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.
Skowronski D; Chambers C; Sabaiduc S; De Serres G; Dickinson J; Winter A; Fonseca K; Gubbay J; Charest H; Petric M; Krajden M; Mahmud S; Van Caeseele P; Kwindt T; Eshaghi A; Bastien N; Li Y
Euro Surveill; 2014 Feb; 19(5):. PubMed ID: 24524234
[TBL] [Abstract][Full Text] [Related]
14. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
15. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
16. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
[TBL] [Abstract][Full Text] [Related]
18. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
19. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.
Castilla J; Martínez-Baz I; Martínez-Artola V; Reina G; Pozo F; García Cenoz M; Guevara M; Morán J; Irisarri F; Arriazu M; Albéniz E; Ezpeleta C; Barricarte A; ;
Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399423
[TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.
Castilla J; Martínez-Baz I; Navascués A; Fernandez-Alonso M; Reina G; Guevara M; Chamorro J; Ortega MT; Albéniz E; Pozo F; Ezpeleta C; ;
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
